Ping An Insurance (Group) Company of China (2318.HK) Earnings Analysis
Ping An Insurance (Group) Company of China (2318.HK) next reports earnings on 2026-08-21. It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 7.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2318.HK next report earnings?
| Next earnings date | 2026-08-21 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 215.40B |
2318.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | 1.42 HKD | n/a | n/a | n/a |
| 2025-08-26 | 2.39 HKD | n/a | n/a | n/a |
| 2025-03-19 | 0.4362 HKD | 0.692 HKD | -37% | Miss |
| 2024-10-21 | 2.72 HKD | 1.79 HKD | +52% | Beat |
| 2024-08-22 | 2.25 HKD | 2.43 HKD | -7.4% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
2318.HK valuation and analyst view
| Trailing P/E | 7.38 |
|---|---|
| Trailing EPS | 7.333 HKD |
| Price / book | 0.97 |
| Dividend yield | 4.97% |
| Market cap | 1023.08B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ping An Insurance (Group) Company of China (2318.HK)'s next earnings date?
Ping An Insurance (Group) Company of China is next scheduled to report on 2026-08-21 and revenue estimate of 215.40B.
Did 2318.HK beat earnings last quarter?
Consensus estimate data was not available for 2318.HK's 2026-04-27 report.
What is 2318.HK's earnings track record?
Over the last 3 reported quarters with consensus data, 2318.HK beat estimates 1 times (33%).
What is 2318.HK's current P/E ratio and EPS?
2318.HK trades at a trailing P/E of 7.38 on trailing EPS of 7.333036515742911 HKD.
What do analysts rate 2318.HK?
2318.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.